Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout ; volume:22 ; number:1 ; day:12 ; month:3 ; year:2020 ; pages:1-10 ; date:12.2020
Arthritis Research & Therapy ; 22, Heft 1 (12.3.2020), 1-10, 12.2020
- Urheber
-
Wrigley, Rebekah
Phipps-Green, Amanda J.
Topless, Ruth K.
Major, Tanya J.
Cadzow, Murray
Riches, Philip
Tausche, Anne-Kathrin
Janssen, Matthijs
Joosten, Leo A. B.
Jansen, Tim L.
So, Alexander
Harré Hindmarsh, Jennie
Stamp, Lisa K.
Dalbeth, Nicola
Merriman, Tony
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-020-2136-z
- URN
-
urn:nbn:de:101:1-2020060405580689554971
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wrigley, Rebekah
- Phipps-Green, Amanda J.
- Topless, Ruth K.
- Major, Tanya J.
- Cadzow, Murray
- Riches, Philip
- Tausche, Anne-Kathrin
- Janssen, Matthijs
- Joosten, Leo A. B.
- Jansen, Tim L.
- So, Alexander
- Harré Hindmarsh, Jennie
- Stamp, Lisa K.
- Dalbeth, Nicola
- Merriman, Tony
- SpringerLink (Online service)
Ähnliche Objekte (12)
Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2
Epistatic interaction between PKD2 and ABCG2 influences the pathogenesis of hyperuricemia and gout
Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia
Susceptibility genes of hyperuricemia and gout
ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study
The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients
Influence of the ABCG2 gout risk 141 K allele on urate metabolism during a fructose challenge
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
Circulating microRNA alternations in primary hyperuricemia and gout
Variation in serum urate levels in the absence of gout and urate lowering therapy
Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2
Epistatic interaction between PKD2 and ABCG2 influences the pathogenesis of hyperuricemia and gout
Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia
Susceptibility genes of hyperuricemia and gout
ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study
The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients
Influence of the ABCG2 gout risk 141 K allele on urate metabolism during a fructose challenge
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
Circulating microRNA alternations in primary hyperuricemia and gout
Variation in serum urate levels in the absence of gout and urate lowering therapy
Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Familial early-onset hyperuricemia and gout associated with a newly identified dysfunctional variant in urate transporter ABCG2
Epistatic interaction between PKD2 and ABCG2 influences the pathogenesis of hyperuricemia and gout
Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia
Susceptibility genes of hyperuricemia and gout
ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study
The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients
Influence of the ABCG2 gout risk 141 K allele on urate metabolism during a fructose challenge
Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment
Circulating microRNA alternations in primary hyperuricemia and gout
Variation in serum urate levels in the absence of gout and urate lowering therapy
Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study